Type 1 diabetes

Early Appearance of Thyroid Autoimmunity in Children Followed From Birth for Type 1 Diabetes Risk

J Clin Endocrinol MetabPublished Prospective cohort study

Authors' conclusion

Thyroid autoantibodies may appear during the first years of life, especially in girls, and in children with a family history of AITD. Simultaneous appearance of both autoantibodies increases the risk for hypothyroidism or hyperthyroidism.

Study context

Population
Healthy children with human leukocyte antigen (HLA) DR3- or DR4-containing haplogenotypes, genetically at risk for T1D, from the The Environmental Determinants of Diabetes in the Young (TEDDY) study
Participants
5,066 children
Outcome
Age at seroconversion to TPOAb and TgAb
Methodological detailslongitudinal, retrospective and prospective autoantibody screening
  • Longitudinal
  • Retrospective and prospective autoantibody screening

Main finding

As reported in the abstract

Age at seroconversion

Youngest appearance of TPOAb

10 months

Youngest appearance of TgAb

15 months

Observational data: associations, not effects.

Further findings

Risk of TPOAb with family history of autoimmune thyroid disease (AITD)

HR (95% CI)
Family history of AITD1.90 (1.17–3.08)

Risk of TgAb with family history of AITD

HR (95% CI)
Family history of AITD2.55 (1.91–3.41)
OutcomeHR (95% CI)
Progression to hypothyroidism or hyperthyroidism by first-appearing autoantibodyBoth autoantibodies at same visitvs TPOAb first6.34 (2.72–14.76)

Incidence of TPOAb and TgAb by sex

Girls had higher incidence rates of both autoantibodies

Progression to hypothyroidism or hyperthyroidism by first-appearing autoantibody

Risk not different between TgAb and TPOAb first

Original publication

Early Appearance of Thyroid Autoimmunity in Children Followed From Birth for Type 1 Diabetes Risk. J Clin Endocrinol Metab. Published 12 July 2024. doi:10.1210/clinem/dgae478

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.